The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

elixirmedical.com

About Elixir Medical Corporation

Elixir Medical Corporation is a medical device company developing: Medtronic Endeavor Coronary Stent System.Defines Elixir as a company that combines state of the art medical devices with advanced pharmaceuticals. The first product is a coronary drug eluting stent.

Elixir Medical Corporation Headquarter Location

870 Hermosa Ave

Sunnyvale, California, 94085,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Elixir Medical Corporation Patents

Elixir Medical Corporation has filed 45 patents.

The 3 most popular patent topics include:

  • Implants (medicine)
  • Prosthetics
  • Cardiac surgery
patents chart

Application Date

Grant Date

Title

Related Topics

Status

3/8/2021

12/7/2021

Cardiac anatomy, Cardiac surgery, Valvular heart disease, Cardiology, Congenital heart defects

Grant

Application Date

3/8/2021

Grant Date

12/7/2021

Title

Related Topics

Cardiac anatomy, Cardiac surgery, Valvular heart disease, Cardiology, Congenital heart defects

Status

Grant

Latest Elixir Medical Corporation News

Stents Market revenue to cross USD 11.4 billion by 2028, Says Global Market Insights Inc.

May 10, 2022

Selbyville, Delaware , May 10, 2022 (GLOBE NEWSWIRE) -- The stents market value is projected to reach USD 11.4 billion by 2028, according to a new research report by Global Market Insights Inc. Surge in number of peripheral and coronary artery surgical procedures along with growing demand for minimally invasive techniques will propel market growth. Rising geriatric population coupled with increasing prevalence of chronic diseases including gastrointestinal diseases are expected to fuel the market expansion. Gastrointestinal disorders are increasingly prevalent among the old age population as aging affects multiple functions of the gastrointestinal system such as digestion, motility, enzyme & hormone secretion, and absorption among others. Percutaneous coronary interventions (PCI) are increasingly being utilized in the elderly population owing to advancement in stent technologies that reduced the need for prolonged dual antiplatelet agents in old age population. Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/3372 Vascular stents accounted for USD 7,964.7 million in 2021. Vascular stents are commonly used to prevent vessel closures and later restenosis in the treatment of arterial stenosis in coronary arteries. Additionally, increasing number of patients suffering from chronic obstructive pulmonary disease (COPD) will foster the market demand. Some major findings of the stents market report include: Various technological advancements in coronary stents will boost the industry forecasts. Adoption of novel technology coupled with rising focus on enhancing the healthcare infrastructure in Asia Pacific region will influence the market statistics. Competitors focus on geographic expansion and development of patient-specific stent designs to strengthen their market position. Browse key industry insights spread across 300 pages with 707 market data tables & 20 figures & charts from the report, “Stents Market Size By Product (Vascular Stents [Coronary Stents {Bare Metal Stents, Drug Eluting Stents, Bioresorbable Stents}, Peripheral Stents {Iliac Stents, Femoral-Popliteal Stents, Renal Stents, Carotid Stents}, Neurovascular Stents], Non-vascular Stents), Material (Metal, Polymer), Type, (Self-expandable Stents, Balloon-expandable Stents), End-use (Hospitals, Ambulatory Surgical Centers), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2022 - 2028” in detail along with the table of contents: Metal stents segment is estimated to surpass USD 8,953 million by 2028. Metal stents are self-expanding scaffolding and are widely used in cardiology for maintaining coronary artery patency. Furthermore, metal stents successfully reduce the incidence of abrupt closure and restenosis thereby, reduces the chances of revascularization. Metal stents also possess various advantages over polymer stents as they do not occlude side branches because of mesh structure and tumor growth occurs less frequently. Moreover, the metal stents provide improved safety over angioplasty, intimal hyperplasia, and subsequent restenosis. Balloon expandable stents segment accounted for 63.6% revenue share in 2021 is set to register a significant CAGR through 2028. The balloon expended stents are composed of thin cobalt structs that have closed cell design for tight scaffolding. Balloon expandable stents are used to prevent coronary restenosis after coronary angioplasty and treats restenosis in the iliac artery by opening the clogged arteries and restores blood flow. Furthermore, balloon expandable stents are rigid and support high radial outward force that enables to be placed with great precision. China stents market is poised to show robust CAGR of 5.1% during the forecast timeframe. This is attributed to increasing prevalence of cardiovascular disease. Various key market players are focusing on novel product development and increasing adoption of novel technologically advance tools to achieve effective surgical outcomes and reduce the post-operative trauma will augment the regional industry revenue. Also increasing geriatric population and growing awareness for stents procedure will drive the business landscape. Request for customization of this research report @ https://www.gminsights.com/roc/3372 Few market players operating in the stents industry include Abbott Laboratories, B. Braun Melsungen AG, MicroPort Scientific Corporation, Medtronic, Boston Scientific, Terumo, Biosensors International Group, Biotronik, Elixir Medical Corporation and Meril Life Sciences. About Global Market Insights Global Market Insights Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy, and biotechnology.

Elixir Medical Corporation Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Elixir Medical Corporation Rank

  • Where is Elixir Medical Corporation's headquarters?

    Elixir Medical Corporation's headquarters is located at 870 Hermosa Ave, Sunnyvale.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.